Market Exclusive

Analyst Activity – Leerink Swann Lowers Its Price Target On Bristol-Myers Squibb Company (NYSE:BMY) to $61.00

Analyst Ratings For Bristol-Myers Squibb Company (NYSE:BMY)

Today, Leerink Swann lowered its price target on Bristol-Myers Squibb Company (NYSE:BMY) to $61.00 per share.

There are 1 sell rating, 10 hold ratings, 10 buy ratings on the stock.

The current consensus rating on Bristol-Myers Squibb Company (NYSE:BMY) is Hold (Score: 2.43) with a consensus target price of $63.00 per share, a potential 13.99% upside.

Some recent analyst ratings include

Dividend information for Bristol-Myers Squibb Company (NYSE:BMY)

Bristol-Myers Squibb Company (NYSE:BMY) pays an annual dividend of Community Ranking: with a yield of 2.82% and an average dividend growth of 2.80% based on a 3 Year Average.

Dividend History for Bristol-Myers Squibb Company (NYSE:BMY)

Recent Insider Trading Activity For Bristol-Myers Squibb Company (NYSE:BMY)
Bristol-Myers Squibb Company (NYSE:BMY) has insider ownership of 0.23% and institutional ownership of 69.72%.

Recent Trading Activity for Bristol-Myers Squibb Company (NYSE:BMY)
Shares of Bristol-Myers Squibb Company closed the previous trading session at 55.27 up +1.03 1.90% with 9,054,454 shares trading hands.

Exit mobile version